We have located links that may give you full text access.
Reproductive and Neurobehavioral Effects of Ethiprole Administered to Mice in the Diet.
Birth Defects Research 2017 November 16
BACKGROUND: Few studies were found for neurobehavioral toxicity of the phenylpyrazole insecticide ethiprole in mammals. This study was designed to evaluate the reproductive and neurobehavioral effects of ethiprole exposure in mice.
METHODS: Ethiprole was given in the diet to provide levels of 0 (control), 0.0003, 0.0009, and 0.0027% from 5 weeks of age of the F0 generation to 11 weeks of age of the F1 generation in mice. Selected reproductive and neurobehavioral parameters were measured.
RESULTS: Movement time increased with a significant dose-related trend, and frequencies of mice with urination increased in the high-dose group of adult males in the F0 generation. The average body weight of male and female offspring increased significantly in treatment groups at postnatal days (PNDs) 7, 14, and 21. Surface righting on PND 7 of male offspring was accelerated in a significant dose-related trend. In female offspring, olfactory orientation on PND 14 was accelerated significantly on the route of higher-dose groups, and time of all treatment groups. Total distance, movement time, average speed, and average time of movement significantly decreased, and frequencies of mice with urination increased in a significant dose-related trend in male offspring in the F1 generation. Longitudinal patterns of spontaneous behavior differed in the number of horizontal activities, movement time, and average speed in treatment groups in males. The number of horizontal activities of females decreased in a significant dose-related trend through 120 min.
CONCLUSION: The dose levels of ethiprole in the present study produced several adverse effects in neurobehavioral parameters in mice. Birth Defects Research 109:1568-1585, 2017. © 2017 Wiley Periodicals, Inc.
METHODS: Ethiprole was given in the diet to provide levels of 0 (control), 0.0003, 0.0009, and 0.0027% from 5 weeks of age of the F0 generation to 11 weeks of age of the F1 generation in mice. Selected reproductive and neurobehavioral parameters were measured.
RESULTS: Movement time increased with a significant dose-related trend, and frequencies of mice with urination increased in the high-dose group of adult males in the F0 generation. The average body weight of male and female offspring increased significantly in treatment groups at postnatal days (PNDs) 7, 14, and 21. Surface righting on PND 7 of male offspring was accelerated in a significant dose-related trend. In female offspring, olfactory orientation on PND 14 was accelerated significantly on the route of higher-dose groups, and time of all treatment groups. Total distance, movement time, average speed, and average time of movement significantly decreased, and frequencies of mice with urination increased in a significant dose-related trend in male offspring in the F1 generation. Longitudinal patterns of spontaneous behavior differed in the number of horizontal activities, movement time, and average speed in treatment groups in males. The number of horizontal activities of females decreased in a significant dose-related trend through 120 min.
CONCLUSION: The dose levels of ethiprole in the present study produced several adverse effects in neurobehavioral parameters in mice. Birth Defects Research 109:1568-1585, 2017. © 2017 Wiley Periodicals, Inc.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app